| Mary Margaret Haus, MD | |
|
2000 Eoff St, Suite 603, Wheeling, WV 26003-3823 | |
| (304) 234-3405 | |
| (304) 234-3406 |
| Full Name | Mary Margaret Haus |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 44 Years |
| Location | 2000 Eoff St, Wheeling, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376530717 | NPI | - | NPPES |
| 2694713 | Medicaid | OH | |
| 3810006065 | Medicaid | WV | |
| P00345755 | Other | WV | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD039107L (Pennsylvania) | Secondary |
| 207X00000X | Orthopaedic Surgery | 01625 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Medical Group, Llc | 7719040385 | 218 |
News Archive
Zimmer Holdings, Inc. announced today that it has commenced a $550 million public offering of senior notes.
Harnessing the power of social media, medical researchers have sifted through more than two billion tweets and online posts to study the harmful side effects of narcotics medication taken for chronic pain.
Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of reperfusion therapy's narrow treatment window.
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease.
› Verified 8 days ago
| Entity Name | Genesis Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063663433 PECOS PAC ID: 7719040385 Enrollment ID: O20090107000547 |
News Archive
Zimmer Holdings, Inc. announced today that it has commenced a $550 million public offering of senior notes.
Harnessing the power of social media, medical researchers have sifted through more than two billion tweets and online posts to study the harmful side effects of narcotics medication taken for chronic pain.
Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of reperfusion therapy's narrow treatment window.
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Margaret Haus, MD 2000 Eoff St, Wheeling, WV 26003-3823 Ph: (304) 234-8663 | Mary Margaret Haus, MD 2000 Eoff St, Suite 603, Wheeling, WV 26003-3823 Ph: (304) 234-3405 |
News Archive
Zimmer Holdings, Inc. announced today that it has commenced a $550 million public offering of senior notes.
Harnessing the power of social media, medical researchers have sifted through more than two billion tweets and online posts to study the harmful side effects of narcotics medication taken for chronic pain.
Reperfusion therapy, the gold standard for stroke treatment, helps restore blood flow after a stroke caused by a clot, preventing loss of brain tissue. However, only about 10% of stroke patients qualify, in part because of reperfusion therapy's narrow treatment window.
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease.
› Verified 8 days ago
Dr. Ronald Angelo Sismondo Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Ste 101, Wheeling, WV 26003 Phone: 304-231-2090 | |
Derek Hugh Andreini, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park, Suite 703, Wheeling, WV 26003 Phone: 304-242-6373 Fax: 304-242-6371 | |
Dr. Robert A Caveney, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2115 Chapline St, Ste 107, Wheeling, WV 26003 Phone: 304-243-1050 Fax: 304-243-0140 | |
Robert J Zaleski, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10 Medical Park Ste 203, Wheeling, WV 26003 Phone: 304-242-9460 Fax: 304-242-6958 | |
Jeffrey Michael Abbott, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10 Medical Park, Suite 206, Wheeling, WV 26003 Phone: 304-243-6534 Fax: 304-243-8575 |